<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BC3595B7-7C8F-45BE-BEF2-589561222BF4"><gtr:id>BC3595B7-7C8F-45BE-BEF2-589561222BF4</gtr:id><gtr:name>Invibio</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Electronics and Computer Science</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BC3595B7-7C8F-45BE-BEF2-589561222BF4"><gtr:id>BC3595B7-7C8F-45BE-BEF2-589561222BF4</gtr:id><gtr:name>Invibio</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E16D3EA-8DD1-4FDE-B49A-49FFC439A57A"><gtr:id>1E16D3EA-8DD1-4FDE-B49A-49FFC439A57A</gtr:id><gtr:name>Huxley Bertram Engineering</gtr:name><gtr:address><gtr:line1>Brookfield Centre</gtr:line1><gtr:line2>Cottenham</gtr:line2><gtr:postCode>CB24 8PS</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/304EB043-3B9D-46C7-9521-B96C2594EB6D"><gtr:id>304EB043-3B9D-46C7-9521-B96C2594EB6D</gtr:id><gtr:name>IP Group Plc</gtr:name><gtr:address><gtr:line1>24 Cornhill</gtr:line1><gtr:postCode>EC3V 3ND</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C0D0F832-C1E6-4258-9CA4-AD45E59C4B94"><gtr:id>C0D0F832-C1E6-4258-9CA4-AD45E59C4B94</gtr:id><gtr:firstName>Shoufeng</gtr:firstName><gtr:surname>Yang</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FH502319%2F2"><gtr:id>EB5F6743-E5BD-44D8-A06B-8E8152AAE048</gtr:id><gtr:title>A Dry Powder Jet Printer for Dispensing Pharmaceutical Powders.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/H502319/2</gtr:grantReference><gtr:abstractText>The specific aim of this project is to develop the QMUL technology to a bench-top powder dispensing system. The commercial product will be market ready within 2 years, providing a lower cost, more accurate system compared to competitors, such as Symyx Powdernium, FlexiWeigh and BIODOT DisPoTM. The bench-top system will act as a first step in validating the technology for scale-up to high-value applications, such as production-line filing of capsules and blisters with pharmaceutical drugs and combinatorial research. The bench-top system will be developed in partnership with Huxley Bertram Ltd, an established engineering company with expertise in designing and developing equipment for the pharmaceutical industry</gtr:abstractText><gtr:fund><gtr:end>2011-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2010-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>62615</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Invibio</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GSK</gtr:description><gtr:id>20AD1CA2-2055-4AB9-AA89-F2A91E4FE62C</gtr:id><gtr:impact>More collaboration is on going</gtr:impact><gtr:outcomeId>56df571474d821.27672139-2</gtr:outcomeId><gtr:partnerContribution>provide powders and meetings and cash</gtr:partnerContribution><gtr:piContribution>pharmaceutical powder dispensing trial and 3D printing of PEEK</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK</gtr:description><gtr:id>5F053796-85BD-46A9-82A7-EA477F945CAA</gtr:id><gtr:impact>More collaboration is on going</gtr:impact><gtr:outcomeId>56df571474d821.27672139-1</gtr:outcomeId><gtr:partnerContribution>provide powders and meetings and cash</gtr:partnerContribution><gtr:piContribution>pharmaceutical powder dispensing trial and 3D printing of PEEK</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The funding has been used to further develop the micro dry powder dispensing technology for pharmaceutical powder applications. A spin off company has been established.</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>FDA84714-8385-4972-89BF-77E7BEA0EF4D</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56df0299a6d5f9.57606363</gtr:outcomeId><gtr:sector>Aerospace, Defence and Marine,Agriculture, Food and Drink,Chemicals,Construction,Creative Economy,Electronics,Energy,Environment,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology,Security and Diplomacy,Transport</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200?m to 3mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/2</gtr:grantRef><gtr:id>777AACDB-F6F7-49D1-A77C-FBE3F884A48E</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df50080f91f3.63249762</gtr:outcomeId><gtr:patentId>EP 2467681 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5 mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200 ?m to 3 mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/2</gtr:grantRef><gtr:id>1C10FEB6-8A38-4450-A3BF-3FF4F9CD3CB7</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df5260400806.20355355</gtr:outcomeId><gtr:patentId>US 20120145806 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders US 20120145806 A1</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200?m to 3mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/2</gtr:grantRef><gtr:id>6AAED842-6792-4094-ACDB-136B18EA2540</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df536019e365.07798739</gtr:outcomeId><gtr:patentId>GB 2472817 A</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200?m to 3mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/2</gtr:grantRef><gtr:id>0EBEE51B-3E0D-4B9A-A90E-A6C0760E193F</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df5072af3516.07560493</gtr:outcomeId><gtr:patentId>WO 2011020862 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Further development of this novel dry powder micro dispensing device on various pharmaceutical powders have been conducted using this grant. A large number of pharmaceutical companies were contacted and a spin off companies called VaryDose were established. There were some sales. However due to the difficulties of the management team to secure enough investment, the development is slow.</gtr:description><gtr:exploitationPathways>Similar ideas have been adopted and commercialized by a German company who has marketed it as a new benchmark of pharmaceutical powder handling, due to lack of money for patent protection from University. Further development on 3D printing application has lead to more research and academic and commercial interests.</gtr:exploitationPathways><gtr:id>D78D0C37-9253-4A68-93B7-CD6F5A6AB1A1</gtr:id><gtr:outcomeId>56dccfaf75d708.13421095</gtr:outcomeId><gtr:sectors><gtr:sector>Aerospace, Defence and Marine,Agriculture, Food and Drink,Chemicals,Construction,Creative Economy,Education,Electronics,Energy,Environment,Healthcare,Leisure Activities, including Sports, Recreation and Tourism,Manufacturing, including Industrial Biotechology,Culture, Heritage, Museums and Collections,Pharmaceuticals and Medical Biotechnology,Security and Diplomacy,Transport</gtr:sector></gtr:sectors><gtr:url>http://www.varydose.com/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>VaryDose Ltd</gtr:companyName><gtr:description>The company was spin out to commercialization the dry powder micro dispensing technology on pharmaceutical application.</gtr:description><gtr:id>C0BD4243-938B-4210-8DA5-B78C050424ED</gtr:id><gtr:impact>Application of the dry powder micro dispensing technology on pharmaceutical powders have been demonstrated. Great interests from pharmaceutical companies have been seen.</gtr:impact><gtr:outcomeId>56df20ab6e0cb5.04096362</gtr:outcomeId><gtr:url>http://www.varydose.com</gtr:url><gtr:yearCompanyFormed>2010</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>1E20591F-A9B2-433C-8B1F-6732EB679ECF</gtr:id><gtr:title>The effect of signal amplitude of an ultrasonic vibration controlled metering device on micro-dispensing of inhalation grade lactose</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feca0ea30d543cacc41a19f8a5987a75"><gtr:id>feca0ea30d543cacc41a19f8a5987a75</gtr:id><gtr:otherNames>Prashant Balani</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_3444549581cac7eb80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A54001B2-CCD0-46B5-BFA4-AC12B5AECA51</gtr:id><gtr:title>On the bridging mechanism in vibration controlled dispensing of pharmaceutical powders from a micro hopper</gtr:title><gtr:parentPublicationTitle>Powder Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e22a94e0024bfaaaef288c9d2e81f3bf"><gtr:id>e22a94e0024bfaaaef288c9d2e81f3bf</gtr:id><gtr:otherNames>Jasion G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56df4aa5a6b3b7.98112847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ACF1212-F1AE-4FD0-8424-26C71FB1AA57</gtr:id><gtr:title>The control of microdispensed mean dose of inhalac70 by varying the time period of vibration in an acoustic micro-dosing system</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feca0ea30d543cacc41a19f8a5987a75"><gtr:id>feca0ea30d543cacc41a19f8a5987a75</gtr:id><gtr:otherNames>Prashant Balani</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_2488375747cac7d0a0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B2DA791-BC9E-40DE-9264-795675802ADD</gtr:id><gtr:title>The role of nozzle size of an acoustic vibration controlled micro-dosing system on micro-dispensing of inhalac70</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feca0ea30d543cacc41a19f8a5987a75"><gtr:id>feca0ea30d543cacc41a19f8a5987a75</gtr:id><gtr:otherNames>Prashant Balani</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_9660595011cac82bc2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/H502319/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>3B1E3AAB-D2E6-410C-A06C-E8CA1788E272</gtr:id><gtr:grantRef>EP/H502319/1</gtr:grantRef><gtr:amount>81014.17</gtr:amount><gtr:start>2010-06-01</gtr:start><gtr:end>2010-09-01</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>EB5F6743-E5BD-44D8-A06B-8E8152AAE048</gtr:id><gtr:grantRef>EP/H502319/2</gtr:grantRef><gtr:amount>62615.38</gtr:amount><gtr:start>2010-09-01</gtr:start><gtr:end>2011-08-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>D513F43E-F19D-4AB3-8E03-A47B085709AB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Materials Processing</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>B30DC286-3309-48E2-A15D-BDF547057A33</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Drug Formulation &amp; Delivery</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D513F43E-F19D-4AB3-8E03-A47B085709AB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Materials Processing</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>